Even with conventional intensive insulin therapy, frequent hypoglycemia (estimated at 5–15% of total blood glucose measurements) is often necessary to maintain the mean glycemic level within treatment targets (<150 mg/dL) [1]. This evidence concerns the gene INS and Hypoglycemia.